Horacio Galan-Alonso

San Sebastian, PV, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Effectiveness and safety of rectal tacrolimus in patients with ulcerative colitis. TACRO-TOPIC study of GETECCU.

Effectiveness and safety of rectal tacrolimus in patients with ulcerative colitis. TACRO-TOPIC study of GETECCU.

Journal: Journal of Crohn's & colitis
Published: April 10, 2025

Natural history, immunological and genetic characteristics of preclinical inflammatory bowel disease (EARLY): study protocol for a prospective cohort study.

Natural history, immunological and genetic characteristics of preclinical inflammatory bowel disease (EARLY): study protocol for a prospective cohort study.

Journal: Therapeutic advances in gastroenterology
Published: July 24, 2024

Persistence, Effectiveness, and Safety of Upadacitinib in Crohn's Disease and Ulcerative Colitis in Real Life: Results From a Spanish Nationwide Study (Ureal Study).

Persistence, Effectiveness, and Safety of Upadacitinib in Crohn's Disease and Ulcerative Colitis in Real Life: Results From a Spanish Nationwide Study (Ureal Study).

Journal: The American journal of gastroenterology
Published: July 17, 2024

Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study.

Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study.

Journal: Alimentary pharmacology & therapeutics
Published: June 09, 2024

Organic dyspepsia until proven otherwise.

Organic dyspepsia until proven otherwise.

Journal: Revista espanola de enfermedades digestivas
Published: February 12, 2024

The Natural History of Patients With Pre-Existing and De Novo Inflammatory Bowel Disease After Solid Organ Transplantation: EITOS Study of GETECCU.

The Natural History of Patients With Pre-Existing and De Novo Inflammatory Bowel Disease After Solid Organ Transplantation: EITOS Study of GETECCU.

Journal: Inflammatory bowel diseases
Published: August 28, 2023

IgA vasculitis (Henoch- Schönlein purpura) with gastrointestinal involvement.

IgA vasculitis (Henoch- Schönlein purpura) with gastrointestinal involvement.

Journal: Revista espanola de enfermedades digestivas
Published: November 25, 2022

Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case-Control Study (COVID-19-EII).

Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case-Control Study (COVID-19-EII).

Journal: Journal of clinical medicine
Published: September 18, 2022

Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety.

Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety.

Journal: The American journal of gastroenterology
Published: July 13, 2022

Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10, 2885.

Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10, 2885.

Journal: Journal of clinical medicine
Published: May 26, 2022

Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry.

Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry.

Journal: Journal of clinical medicine
Published: December 09, 2021

Local genetic variation of inflammatory bowel disease in Basque population and its effect in risk prediction.

Local genetic variation of inflammatory bowel disease in Basque population and its effect in risk prediction.

Journal: Scientific reports
Published: July 21, 2021
Showing 1-12 of 16

Last Updated: 09/26/2026